Sign up for free insights newsletter
68

APT Medical Inc

688617SHG

Need professional-grade analysis? Visit stockanalysis.com

CN¥225.95
-2.44%
End of day
Market Cap

$33.38B

P/E Ratio

43.59

Employees

2,555

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-1.74-0.51-1.06
Calmar-1.57-0.38-0.91
Sharpe-1.30-0.34-0.77
Omega0.700.960.85
Martin-2.18-0.73-1.38
Ulcer23.2916.7519.66

APT Medical Inc (688617) Price Performance

APT Medical Inc (688617) trades on SHG in CNY. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at CNY225.95, down 2.44% from the previous close.

Over the past year, 688617 has traded between a low of CNY224.40 and a high of CNY331.86. The stock has lost 12.7% over this period. It is currently 31.9% below its 52-week high.

APT Medical Inc has a market capitalization of $33.38B, with a price-to-earnings ratio of 43.59.

About APT Medical Inc

APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. The company offers electrophysiology products, such as mapping, ablation, and navigated catheter, as well as steerable, and transseptal needle and sheet; and interventional cardiology and peripheral products, including access, diagnostic, therapeutic, and accessories. It also provides OEM/ODM service comprising project design and development, customization, and volume OEM for use in catheters, guidewires, delivery systems, nitinol products in cardiology, peripheral, neurology, and urology. APT Medical Inc. was founded in 2002 and is based in Shenzhen, China.

Company Info

Exchange
SHG
Currency
CNY
Country
China

Financial Metrics

Revenue (TTM)
$2.58B
EBITDA
$1.02B
Profit Margin
31.76%
EPS (TTM)
5.43
Book Value
21.20

Technical Indicators

52 Week High
CN¥337.20
52 Week Low
CN¥222.12
50 Day MA
CN¥238.13
200 Day MA
CN¥272.16
Beta
-0.31

Valuation

Trailing P/E
43.59
Forward P/E
N/A
Price/Sales
12.92
Price/Book
11.10
Enterprise Value
$31.82B